These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 16426914

  • 1. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA, Craig FE, Swerdlow SH.
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [Abstract] [Full Text] [Related]

  • 2. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
    Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A'Hern R, Brito-Babapulle V, Catovsky D.
    Cancer; 2005 Nov 15; 104(10):2124-32. PubMed ID: 16211545
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U, Bock O, Vornhusen S, Jäger A, Büsche G, Lehmann U, Kreipe H.
    Hum Pathol; 2006 Sep 15; 37(9):1153-61. PubMed ID: 16938520
    [Abstract] [Full Text] [Related]

  • 4. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK, El-Din MS, Azmy E.
    Hematol Oncol; 2009 Jun 15; 27(2):82-9. PubMed ID: 19247976
    [Abstract] [Full Text] [Related]

  • 5. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M, Noguera ME, Gisselbrecht C, Haddad A, Brice P, Marolleau JP, Soulier J, Mounier N.
    Clin Adv Hematol Oncol; 2008 Jan 15; 6(1):55-63. PubMed ID: 18322442
    [Abstract] [Full Text] [Related]

  • 6. Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Igawa T, Sato Y, Takata K, Fushimi S, Tamura M, Nakamura N, Maeda Y, Orita Y, Tanimoto M, Yoshino T.
    Cancer Sci; 2011 Nov 15; 102(11):2103-7. PubMed ID: 21790895
    [Abstract] [Full Text] [Related]

  • 7. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar 15; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 8. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.
    Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718
    [Abstract] [Full Text] [Related]

  • 9. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gong JZ, Lagoo AS, Peters D, Horvatinovich J, Benz P, Buckley PJ.
    Am J Clin Pathol; 2001 Dec 15; 116(6):893-7. PubMed ID: 11764079
    [Abstract] [Full Text] [Related]

  • 10. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E, Domingo-Clarós A, Gonzàlez-Barca E, Beneitez D, Alonso E, Romagosa V, De Sanjos S, Petit J, Grañena A, Fernández de Sevilla A.
    Haematologica; 2002 Oct 15; 87(10):1021-7. PubMed ID: 12368155
    [Abstract] [Full Text] [Related]

  • 11. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R, Ambrosetti A, Lestani M, Ghia P, Pattaro C, Remo A, Zanetti F, Stella S, Perbellini O, Prato G, Guida G, Caligaris-Cappio F, Menestrina F, Pizzolo G, Chilosi M.
    Leukemia; 2007 Jan 15; 21(1):102-9. PubMed ID: 17082778
    [Abstract] [Full Text] [Related]

  • 12. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L, Lasa A, Carricondo MT, Hernández C, Ubeda J, Nomdedéu JF.
    Cytometry B Clin Cytom; 2007 Mar 15; 72(2):96-102. PubMed ID: 17051526
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G, Tarnani M, Rumi C, Vaisitti T, Aydin S, De Filippi R, Perrone F, Pinto A, Chiusolo P, Deaglio S, Malavasi F, Laurenti L.
    Am J Hematol; 2007 Sep 15; 82(9):787-91. PubMed ID: 17534928
    [Abstract] [Full Text] [Related]

  • 14. Prognostic markers in chronic lymphocytic leukaemia.
    Hamblin TJ.
    Best Pract Res Clin Haematol; 2007 Sep 15; 20(3):455-68. PubMed ID: 17707833
    [Abstract] [Full Text] [Related]

  • 15. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
    Cruse JM, Lewis RE, Webb RN, Sanders CM, Suggs JL.
    Exp Mol Pathol; 2007 Dec 15; 83(3):459-61. PubMed ID: 17931624
    [Abstract] [Full Text] [Related]

  • 16. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.
    Dunphy CH, Wheaton SE, Perkins SL.
    Mod Pathol; 1997 Aug 15; 10(8):818-22. PubMed ID: 9267825
    [Abstract] [Full Text] [Related]

  • 17. A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia.
    Hassanein NM, Perkinson KR, Alcancia F, Goodman BK, Weinberg JB, Lagoo AS.
    Am J Clin Pathol; 2010 May 15; 133(5):708-17. PubMed ID: 20395517
    [Abstract] [Full Text] [Related]

  • 18. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
    Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, Blokzijl T, Kooistra K, van T'veer MB, Rosati S, Visser L, Jongen-Lavrencic M, Kluin PM, van den Berg A.
    J Pathol; 2008 May 15; 215(1):13-20. PubMed ID: 18348159
    [Abstract] [Full Text] [Related]

  • 19. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance.
    Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, Attadia V, Rupolo M, Buccisano F, Steffan A, Del Poeta G, Pucillo C, Colombatti A, Campanini R, Gattei V.
    J Immunol Methods; 2005 Oct 20; 305(1):20-32. PubMed ID: 16198366
    [Abstract] [Full Text] [Related]

  • 20. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A, Klein-Hitpass L, Thomale J, Deenen R, Carpinteiro A, Nückel H, Ebeling P, Führer A, Edelmann J, Sellmann L, Dührsen U, Dürig J.
    Leukemia; 2006 Oct 20; 20(10):1774-82. PubMed ID: 16932341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.